11.04
전일 마감가:
$11.04
열려 있는:
$11.14
하루 거래량:
5,300
Relative Volume:
0.02
시가총액:
$122.53M
수익:
$346.10M
순이익/손실:
$-20.02M
주가수익비율:
-6.0553
EPS:
-1.8228
순현금흐름:
$-1.47M
1주 성능:
+4.07%
1개월 성능:
-8.74%
6개월 성능:
+3.29%
1년 성능:
-24.58%
Medifast Inc Stock (MED) Company Profile
명칭
Medifast Inc
전화
(410) 581-8042
주소
1501 S. CLINTON STREET, BALTIMORE, MD
Compare MED vs ROL, SCI, FTDR, HRB, ANDG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
MED
Medifast Inc
|
11.02 | 121.87M | 346.10M | -20.02M | -1.47M | -1.8228 |
|
ROL
Rollins Inc
|
43.88 | 20.89B | 3.84B | 529.30M | 621.14M | 1.0945 |
|
SCI
Service Corp International
|
78.99 | 10.84B | 4.33B | 535.79M | 486.05M | 3.79 |
|
FTDR
Frontdoor Inc
|
79.37 | 5.51B | 2.12B | 260.00M | 385.00M | 3.5067 |
|
HRB
H R Block Inc
|
40.28 | 5.08B | 3.91B | 736.10M | 760.88M | 5.6238 |
|
ANDG
Andersen Group Inc
|
37.55 | 4.11B | 871.37M | -163.01M | 0 | 1.0456 |
Medifast Inc Stock (MED) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-05 | 업그레이드 | DA Davidson | Underperform → Neutral |
| 2024-06-05 | 다운그레이드 | DA Davidson | Neutral → Underperform |
| 2023-10-13 | 개시 | Stephens | Equal-Weight |
| 2022-11-04 | 다운그레이드 | DA Davidson | Buy → Neutral |
| 2022-08-04 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-01-25 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-11-05 | 업그레이드 | DA Davidson | Neutral → Buy |
| 2020-06-25 | 개시 | B. Riley FBR | Buy |
| 2020-02-27 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-11-08 | 다운그레이드 | Dougherty & Company | Buy → Neutral |
| 2019-07-25 | 개시 | Jefferies | Buy |
| 2018-11-08 | 업그레이드 | Sidoti | Neutral → Buy |
| 2018-03-07 | 업그레이드 | Sidoti | Neutral → Buy |
| 2017-09-15 | 재확인 | DA Davidson | Buy |
| 2016-08-04 | 재확인 | Wunderlich | Hold |
| 2016-01-11 | 업그레이드 | Sidoti | Neutral → Buy |
| 2015-11-30 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2015-10-05 | 업그레이드 | Sidoti | Neutral → Buy |
| 2014-11-07 | 다운그레이드 | Imperial Capital | Outperform → In-line |
| 2014-08-08 | 재확인 | Imperial Capital | Outperform |
| 2014-04-23 | 재확인 | Imperial Capital | Outperform |
| 2013-09-06 | 개시 | Imperial Capital | Outperform |
| 2012-11-06 | 재확인 | Northland Securities | Outperform |
| 2012-07-27 | 업그레이드 | Northland Securities | Market Perform → Outperform |
| 2012-07-09 | 다운그레이드 | Standpoint Research | Buy → Hold |
| 2012-01-30 | 개시 | Standpoint Research | Buy |
모두보기
Medifast Inc 주식(MED)의 최신 뉴스
Medifast, Inc.(NYSE: MED) dropped from Russell 2000 Index - marketscreener.com
Medifast, Inc.(NYSE: MED) dropped from Russell 2000 Value-Defensive Index - marketscreener.com
Medifast, Inc.(NYSE: MED) dropped from Russell 2000 Value Benchmark - marketscreener.com
Medifast, Inc.(NYSE: MED) dropped from Russell 2000 Dynamic Index - marketscreener.com
Medifast, Inc.(NYSE: MED) dropped from Russell 3000E Index - marketscreener.com
Price to earnings forward of MEDIFAST INC – NYSE:MED - TradingView
Price to sales forward of MEDIFAST INC – NYSE:MED - TradingView
Price to earnings forward of Medifast, Inc. – BMV:MED - TradingView
OPTAVIA Essential 1 Bar from Medifast Inc.portion-controlled fuel for busy investors - AD HOC NEWS
Enterprise value to EBIT forward of Medifast, Inc. – BMV:MED - TradingView
Medifast, Inc. Actuals & Estimates (BMV:MED) - TradingView
Medifast, Inc. Actuals & Estimates (BOATS:MED) - TradingView
Enterprise value to EBITDA forward of MEDIFAST INC – NYSE:MED - TradingView
Enterprise value to revenue forward of MEDIFAST INC – NYSE:MED - TradingView
Enterprise value to revenue forward of Medifast, Inc. – BIVA:MED - TradingView
Medifast, Inc. Actuals & Estimates (LSE:0K05) - TradingView
Price to book forward of Medifast, Inc. – BIVA:MED - TradingView
Medifast, Inc. Actuals & Estimates (NYSE:MED) - TradingView
Price to sales forward of Medifast, Inc. – BIVA:MED - TradingView
Price to earnings forward of Medifast, Inc. – BIVA:MED - TradingView
Medifast Inc (MED) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MED Forecast — Price Target — Prediction for 2027 - TradingView
Medifast Inc (MED) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Medifast (MED) Loses 18.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Medifast Inc (MED) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Medifast refines its technical picture, shares trade in a narrow Nasdaq range - AD HOC NEWS
Why the Essential 1 Month Kit from Medifast quietly fits busy routines - AD HOC NEWS
MED News | MEDIFAST INC (NYSE:MED) - ChartMill
Medifast StockAnalyst expectations and business outlook - AD HOC NEWS
Medifast (MED) down 5.1% since last earnings report: Can it rebound? - MSN
Medifast Inc (MED) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Medifast Inc (MED) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Medifast Inc (MED) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Medifast Inc (MED) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Medifast Inc (MED) Valuation: PE, PB & Fair Value Analysis - TradingKey
Medifast Inc (MED) Institutional Confidence - TradingKey
New coaching twist, Medifast’s OPTAVIA app deepens its weight-loss ecosystem - AD HOC NEWS
Medifast Inc Stock (US58470S1024): valuation in focus after steep multi-year slide - AD HOC NEWS
What Science-Backed Subscription Health Programs Measure Differently - GlobeNewswire
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Is MEDIFAST (MED) Stock Outpacing Its Consumer Staples Peers This Year? - Yahoo Finance
Medifast chief legal officer Jason Groves resigns; company begins search for successor - Investing.com UK
Medifast chief legal officer Jason Groves resigns; company begins search for successor By Investing.com - Investing.com South Africa
Medifast (MED) Files 8-K Announcing Executive Separation Agreement with Jason Groves - Minichart
Medifast's Jason L. Groves resigns as Chief Legal Officer & Corporate Secretary - TradingView
[8-K] MEDIFAST INC Reports Material Event - Stock Titan
MED News Today | Why did Medifast stock drop today? $MED - MarketBeat
Medifast (MED) director takes equity awards instead of cash for board service - Stock Titan
Medifast (NYSE: MED) director Kiai Parsa takes equity grants in lieu of cash fees - Stock Titan
Medifast (MED) director receives 11,680 RSUs as annual fee compensation - Stock Titan
Medifast (NYSE: MED) director receives 11,680 restricted stock units award - Stock Titan
Medifast Inc (MED) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Medifast Inc 주식 (MED) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SCHLACKMAN SCOTT | Director |
May 11 '26 |
Buy |
12.53 |
2,500 |
31,325 |
30,549 |
| Chard Daniel R | Chairman & CEO |
Mar 20 '26 |
Buy |
10.11 |
17,678 |
178,725 |
17,678 |
자본화:
|
볼륨(24시간):